News about Global Pharma

Aptar Wins CE Mark for LuerVax Vaccine Delivery System

Aptar Pharma has secured CE marking for LuerVax and its spray divider, supporting intranasal vaccine development from clinical studies through commercialisation.

Global Pharma | 15/10/2026 | By News Bureau

Alentis and PinotBio Partner to Develop Claudin-1 ADCs

Alentis and PinotBio have partnered to develop next-generation claudin-1 ADCs, with Alentis securing an exclusive option to license novel linkers and payloads.

Global Pharma | 14/10/2026 | By News Bureau |  104

ArkBio Wins FDA Clearance for AK0406 Phase 2 Trial

ArkBio has received US FDA clearance for its phase 2 AK0406 trial, evaluating influenza prevention in adults during an influenza season.

Global Pharma | 14/10/2026 | By News Bureau |  100

US FDA Approves Drug to Treat Lesions Due to Herpes Simplex Virus

The US FDA has approved a drug to treat Herpes Simplex Virus (HSV-1 and HSV-2) lesions, which can cause painful blisters and mucocutaneous sores.

Global Pharma | 13/10/2026 | By News Bureau |  109

NIH-Supported Study Links Sleep ECG Data to Future Cardiac Risk

NIH-supported study found that combining sleep-stage information with single-lead ECG recordings could help identify people at higher risk of future cardiovascular outcomes.

Global Pharma | 12/10/2026 | By News Bureau |  128

Newron Reviews FDA Feedback on Evenamide Clinical Hold in US

Newron Pharmaceuticals is reviewing FDA feedback on the clinical hold in US study centres for its Phase 3 ENIGMA-TRS 2 trial of evenamide following potential cardiac safety concerns.

Global Pharma | 12/10/2026 | By News Bureau |  106

US FDA Approves Atezolizumab for Stage 3 dMMR Colon Cancer

The US FDA has approved atezolizumab with chemotherapy for stage 3 dMMR colon cancer in patients aged 12 years and older who weigh at least 40 kg.

Global Pharma | 12/10/2026 | By News Bureau

Telomir Pharmaceuticals Secures USD 5.6 Million Financing

Telomir Pharmaceuticals has secured USD 5.6 million in financing as Billionaire Entrepreneur John Paul DeJoria increased his investment.

Global Pharma | 08/10/2026 | By News Bureau |  155

Piramal Pharma Opens New Microbiology Lab in Kentucky

Piramal Pharma Solutions has launched a new microbiology lab and sterility testing suite at its Lexington, Kentucky facility for GMP drug product applications.

Global Pharma | 08/10/2026 | By News Bureau |  107

Sun Pharma Establishes Dermatology Professorship at Mount Sinai

Sun Pharma has established a USD 2.5 million endowed professorship in dermatology at the Icahn School of Medicine at Mount Sinai.

Global Pharma | 07/10/2026 | By News Bureau |  103